George Brady

George is a partner in the firm's Corporate Department.

He has advised on many of the most significant Irish corporate transactions of recent years including:

• Allergan’s $66 billion merger with Actavis;
• unsuccesful bid to acquire eircom from examinership on behalf of an international telecommunications group;
• the Actavis $8.5 billion acquisition of Warner Chilcott;
• the $6.5 billion hostile bid by Royalty Pharma for Elan Corporation;
• Medtronic’s proposed $42.9 billion acquisition of Covidien plc;
• Eaton Corporation’s $11.8 billion acquisition of Cooper Industries;
• the $5.6 billion merger of Questcor and Mallinckrodt;
• Babcock & Brown on its €2.3 billion acquisition of eircom; and
• the $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo International.

George previously worked in the London office of a leading international law firm and has been a partner since 2003.